Patent · US Active

System for gas treatment of a cell implant

US10231817B2 · kind B2 · utility

3Cited by
37References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2014
Grant dateMar 19, 2019
Priority date
Expiry dateOct 16, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02E60/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

System for gas treatment of cellular implants. The system enhances the viability and function of cellular implants, particularly those with high cellular density, for use in human or veterinary medicine. The system utilizes a miniaturized electrochemical gas generator subsystem that continuously supplies oxygen and/or hydrogen to cells within an implantable and immunoisolated cell containment subsystem to facilitate cell viability and function at high cellular density while minimizing overall implant size. The cell containment subsystem is equipped with features to allow gas delivery through porous tubing or gas-only permeable internal gas compartments within the implantable cell containment subsystem. Furthermore, the gas generator subsystem includes components that allow access to water for electrolysis while implanted, thereby promoting long-term implantability of the gas generator subsystem. An application of the system is a pancreatic islet (or pancreatic islet analog) implant for treatment of Type 1 diabetes (T1D) that would be considered a bio-artificial pancreas.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.